Navigation Links
Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail
Date:12/13/2007

Decas SDCs Offer Greater Amounts of the Natural Compound Responsible for

Antioxidant and Anti-adhesion Benefits

CARVER, Mass., Dec. 13 /PRNewswire/ -- Decas Cranberry Products, Inc. announced today the results of new research showing that 1 oz. (or a 1/4 cup) of Decas Sweetened Dried Cranberries (SDCs) has twice the proanthocyanidin (PAC) level of an 8-ounce glass of cranberry juice cocktail. Found abundantly in cranberries, proanthocyanidins (PACs) are natural plant compounds with antioxidant, anti-adhesion and anti-bacterial health promoting properties. Brunswick Laboratories, a leading laboratory specializing in the science of antioxidants, conducted the testing sponsored by Decas.

Cranberry PACs work as an antioxidant to help combat free radical damage in the body and have been shown to be uniquely effective in supporting urinary tract health via their bacterial anti-adhesion ability. According to Ronald L. Prior, Ph.D. of the USDA Arkansas Children's Nutrition Center, cranberries have high antioxidant activity and a unique A-type PAC linkage structure that sets it apart from most other plants. "Brunswick Labs' data on the PAC content of SDCs shows levels much higher than originally reported. Their work confirms that cranberries have been shown to contain the highest level of PACs of most major fruits tested." This new research updates older information about the relative PAC levels found in SDCs and cranberry juice cocktail.

"This new research confirms that Decas SDCs are abundant in proanthocyanidins, or what we call PACs," said Jeff Carlson, president of Decas Cranberry Products, Inc. "That's good news for product developers and manufacturers looking to add healthy ingredients to their product lines. Now they can turn to Decas SDCs for greater amounts of cranberry anti-adhesion and antioxidant power."

According to Carlson, sweetened dried cranberries are one of the fastest growing segments of the cranberry business, and this trend is expected to continue for some time. Currently, Decas SDCs are sold worldwide and used in snack mixes, nutrition bars, cereal mixes, baked goods and salads.

About Brunswick Laboratories

Founded in 1997, Brunswick Laboratories is an independent contract laboratory providing analytical services in the chemical sciences dedicated to "Improving Health Through Science." Equipped with state-of-the-art instrumentation, Brunswick scientists provide superior services and technical support to the nutraceutical, pharmaceutical, food and cosmetic industries.

About Decas Cranberry Products, Inc.

Founded in 1934 and headquartered in Carver, Massachusetts, Decas Cranberry Products, Inc. is the largest independently owned cranberry ingredient company in the world. As The Cranberry Ingredient Experts, Decas supplies premium cranberry products to consumers, retailers and the food industry around the globe. For additional information, visit http://www.decascranberry.com.


'/>"/>
SOURCE Decas Cranberry Products, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):